Related Experiment Video

Updated: Aug 19, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Pomolic acid triggers mitochondria-dependent apoptotic cell death in leukemia cell line

Janaina Fernandes1, Ricardo Weinlich, Rachel Oliveira Castilho

  • 1Instituto de Biofísica Carlos Chagas Filho, UFRJ, Ilha do Fundao, IBCCF, CCS Bl.G, Rio de Janeiro 21949-900, Brazil.

Cancer Letters
|February 8, 2005
PubMed

Insights

Pomolic acid (PA) induces apoptosis in leukemia cells by targeting mitochondria, leading to caspase activation. This suggests PA

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor cells develop anti-apoptotic strategies to resist chemotherapy.
  • Pomolic acid (PA) previously demonstrated efficacy against K562 leukemia and Lucena 1 cells.

Purpose of the Study:

  • To investigate the mechanism of PA-induced apoptosis in HL-60 leukemia cells.
  • To determine if PA can overcome apoptosis resistance in cancer cells.

Main Methods:

  • Induction of apoptosis in HL-60 cells using PA.
  • Measurement of caspase-3 and -9 activation.
  • Assessment of mitochondrial transmembrane potential (Deltapsim) dissipation.
  • Inhibition assays using zVAD-fmk.

Main Results:

  • PA-induced apoptosis in HL-60 cells is mediated by caspase-3 and -9 activation.
  • Mitochondrial transmembrane potential (Deltapsim) dissipation precedes caspase activation.
  • Mitochondria appear to be the primary target of PA, as zVAD-fmk did not inhibit Deltapsim disruption.

Conclusions:

  • PA effectively induces apoptosis in HL-60 cells.
  • Mitochondrial disruption is a key early event in PA-induced apoptosis.
  • PA holds potential for overcoming apoptosis resistance in cancer therapy.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...